Stocks Illumina’s board approved the Grail spin-off in June From ReutersJune 4, 2024 (Reuters) – Illumina’s board has approved the spin-off of Grail, the gene-sequencing machine maker said…
Stocks EU approves Illumina’s plan to sell cancer test maker Grail From ReutersApril 12, 2024 Fu Yun Chi BRUSSELS (Reuters) – U.S. gene sequencing company Illumina’s (NASDAQ:) plan to sell…
